| holdings_name4 = Alexion Pharmaceuticals
| holdings_name8 = Vertex Pharmaceuticals
...
2 KB (201 words) - 18:39, 6 March 2021
| subsid = [[Wikipedia:Alexion Pharmaceuticals|Alexion Pharmaceuticals]]<br />[[Wikipedia:MedImmune|MedImmune]]
...。1993年に英国の化学会社4社から成る[[:en:Imperial Chemical Industries#History|ICI]]が[[:en:pharmaceuticals|医薬品]]事業と[[:en:agrochemicals|農薬]]・特産品事業を[[:en:demerged|分割]]し、[[:en:Zneca|Zen
...
40 KB (1,603 words) - 14:32, 24 August 2023
* [[AAH Pharmaceuticals|AAH]] (subsidiary of Celesio; 1923– )
* [[Acadia Pharmaceuticals|Acadia]] (1993– )
...
14 KB (1,132 words) - 12:42, 6 January 2023
2014年1月、[[Alexion Pharmaceuticals]]はModernaに1億ドルを支払い、ModernaのmRNA治療薬プラットフォームを使用して、[[:en:Crigler-Najjar syndro
...
16 KB (841 words) - 11:23, 2 January 2024
...public resources went into the technology to make antibodies and finally, Alexion, to their credit, kind of picked up the pieces.|[[Sachdev Sidhu]] 2015}}
...ty should not have a premium and orphan drugs should be treated like other pharmaceuticals in general.<ref name="McCabe_2005">{{cite journal |last1=McCabe |first1=C |
...
34 KB (4,782 words) - 08:07, 4 January 2023